| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | VPS10 | 1.32e-05 | 5 | 22 | 2 | IPR006581 | |
| Domain | Sortilin_N | 1.32e-05 | 5 | 22 | 2 | IPR031778 | |
| Domain | Sortilin_C | 1.32e-05 | 5 | 22 | 2 | IPR031777 | |
| Domain | VPS10 | 1.32e-05 | 5 | 22 | 2 | SM00602 | |
| Domain | Sortilin_C | 1.32e-05 | 5 | 22 | 2 | PF15901 | |
| Domain | Sortilin-Vps10 | 1.32e-05 | 5 | 22 | 2 | PF15902 | |
| Domain | PKD | 2.77e-05 | 7 | 22 | 2 | PF00801 | |
| Domain | Sialidases | 4.74e-05 | 9 | 22 | 2 | IPR011040 | |
| Domain | PKD | 7.24e-05 | 11 | 22 | 2 | PS50093 | |
| Domain | PKD_dom | 7.24e-05 | 11 | 22 | 2 | IPR000601 | |
| Domain | - | 7.24e-05 | 11 | 22 | 2 | 2.60.40.670 | |
| Domain | PTPc | 8.14e-04 | 36 | 22 | 2 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 9.56e-04 | 39 | 22 | 2 | PS50055 | |
| Domain | PTPase_domain | 1.06e-03 | 41 | 22 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 1.06e-03 | 41 | 22 | 2 | PF00102 | |
| Domain | PTPc_motif | 2.18e-03 | 59 | 22 | 2 | SM00404 | |
| Domain | Tyr_Pase_cat | 2.18e-03 | 59 | 22 | 2 | IPR003595 | |
| Domain | TYR_PHOSPHATASE_1 | 4.56e-03 | 86 | 22 | 2 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 4.66e-03 | 87 | 22 | 2 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 4.66e-03 | 87 | 22 | 2 | IPR000387 | |
| Domain | - | 5.20e-03 | 92 | 22 | 2 | 3.90.190.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 6.00e-03 | 99 | 22 | 2 | IPR029021 | |
| Domain | PDZ | 1.18e-02 | 141 | 22 | 2 | PF00595 | |
| Domain | PDZ | 1.30e-02 | 148 | 22 | 2 | SM00228 | |
| Domain | - | 1.33e-02 | 150 | 22 | 2 | 2.30.42.10 | |
| Domain | PDZ | 1.35e-02 | 151 | 22 | 2 | PS50106 | |
| Domain | PDZ | 1.37e-02 | 152 | 22 | 2 | IPR001478 | |
| Domain | Ubiquitin-rel_dom | 1.96e-02 | 184 | 22 | 2 | IPR029071 | |
| Pubmed | SORCS1 and SORCS3 control energy balance and orexigenic peptide production. | 3.82e-07 | 2 | 22 | 2 | 29440124 | |
| Pubmed | Identification and characterization of SorCS, a third member of a novel receptor family. | 3.82e-07 | 2 | 22 | 2 | 10600506 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 28827148 | ||
| Pubmed | Spatiotemporal expression analysis of the growth factor receptor SorCS3. | 1.15e-06 | 3 | 22 | 2 | 24715575 | |
| Pubmed | The three sorCS genes are differentially expressed and regulated by synaptic activity. | 1.15e-06 | 3 | 22 | 2 | 15009648 | |
| Pubmed | Amyloidosis causes downregulation of SorLA, SorCS1 and SorCS3 expression in mice. | 1.15e-06 | 3 | 22 | 2 | 31095505 | |
| Pubmed | The genes for the human VPS10 domain-containing receptors are large and contain many small exons. | 2.29e-06 | 4 | 22 | 2 | 11499680 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 14516276 | ||
| Pubmed | 2.97e-05 | 13 | 22 | 2 | 23576434 | ||
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | 4.41e-05 | 318 | 22 | 4 | 16919269 | |
| Pubmed | 4.56e-05 | 16 | 22 | 2 | 18824598 | ||
| Pubmed | 1.27e-04 | 418 | 22 | 4 | 34709266 | ||
| Pubmed | 5.16e-04 | 53 | 22 | 2 | 35216969 | ||
| Pubmed | 5.56e-04 | 55 | 22 | 2 | 18448421 | ||
| Cytoband | 10q23-q25 | 1.31e-06 | 4 | 22 | 2 | 10q23-q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q25 | 1.80e-03 | 131 | 22 | 2 | chr10q25 | |
| GeneFamily | PDZ domain containing | 7.80e-03 | 152 | 16 | 2 | 1220 | |
| Coexpression | GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN | 5.28e-07 | 196 | 22 | 5 | M4431 | |
| Coexpression | PHONG_TNF_RESPONSE_VIA_P38_COMPLETE | 3.37e-05 | 224 | 22 | 4 | M2500 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_500 | 4.48e-05 | 417 | 21 | 5 | gudmap_kidney_adult_RenMedVasc_Tie2_500 | |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_k-means-cluster#3_top-relative-expression-ranked_500 | 8.38e-05 | 87 | 21 | 3 | gudmap_kidney_adult_GlomCapSys_Tie2_k3_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 1.26e-04 | 17 | 21 | 2 | gudmap_kidney_P4_CapMesRenVes_Crym_k4_200 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | 1.51e-04 | 872 | 21 | 6 | gudmap_kidney_adult_Mesangium_Meis_1000 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.44e-07 | 155 | 22 | 4 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.43e-06 | 172 | 22 | 4 | 7e1a7700a4c2b1d100da1d6e475e73498ebb605a | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.83e-06 | 183 | 22 | 4 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-06 | 194 | 22 | 4 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.45e-06 | 197 | 22 | 4 | dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849 | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.45e-06 | 197 | 22 | 4 | 9fcfbfbe78e8fe90c76eb37a58ed9dc8ece652a1 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.45e-06 | 197 | 22 | 4 | ee8f7def9d5af7b1e636830a4ea1da158d02f25a | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_only / Treatment groups by lineage, cell group, cell type | 2.50e-06 | 198 | 22 | 4 | d205dfcfe1f20e1e21bf84759e723d9e6e610a5c | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.55e-06 | 199 | 22 | 4 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.60e-06 | 200 | 22 | 4 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.60e-06 | 200 | 22 | 4 | 1a3d29a580d1b405a74869a1da3e818c581fc559 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.60e-06 | 200 | 22 | 4 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.60e-06 | 200 | 22 | 4 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.60e-06 | 200 | 22 | 4 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.60e-06 | 200 | 22 | 4 | 332905a686356cd1e024d40679be98e9d8b1b5e8 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E---L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.60e-06 | 200 | 22 | 4 | 6f9ed8fe9cda91185c3a1a675353e11b8fec6ef1 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.60e-06 | 200 | 22 | 4 | 86705dfc05b3e1576543b93883c88fb55b742855 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.60e-06 | 200 | 22 | 4 | db194b4f524fd008b3c5b4b6014b436190a1b87a | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.60e-06 | 200 | 22 | 4 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.60e-06 | 200 | 22 | 4 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.60e-06 | 200 | 22 | 4 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.81e-05 | 121 | 22 | 3 | 7f2057367777c6c92f596054cbc5fe567d079fbc | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.03e-05 | 124 | 22 | 3 | 690595d710b57b7cff8029a3bb06a8dd7e3c03c1 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.49e-05 | 130 | 22 | 3 | 8bd038b0423960ffdc6c8b128c46a55386f9c58c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.49e-05 | 130 | 22 | 3 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.26e-05 | 139 | 22 | 3 | 9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.73e-05 | 144 | 22 | 3 | 7de962346ba9653d90dd13bb7d977fe44d200bba | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.23e-05 | 149 | 22 | 3 | 10ffd0051fb027bbebc662ca602c80d89bbf99c6 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.23e-05 | 149 | 22 | 3 | 98ae408d2d0347865875ff8bbd89d359decea526 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.34e-05 | 150 | 22 | 3 | c2c51a3230c978e2fdb1b3ae14193d4014431b25 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.89e-05 | 155 | 22 | 3 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.89e-05 | 155 | 22 | 3 | 99e749f7075e2c64e9a0bf91009f95b6969197c8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.11e-05 | 157 | 22 | 3 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.35e-05 | 159 | 22 | 3 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.35e-05 | 159 | 22 | 3 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.83e-05 | 163 | 22 | 3 | ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.83e-05 | 163 | 22 | 3 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | 390C-Lymphocytic-ILC|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.96e-05 | 164 | 22 | 3 | b0fc63b72162b5cc4d1e0a271a12f3d3ab29398f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.21e-05 | 166 | 22 | 3 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.34e-05 | 167 | 22 | 3 | 1c1b4722c6c0eff85a9b32ca7b4e281caebf63b0 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 7.61e-05 | 169 | 22 | 3 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 7.74e-05 | 170 | 22 | 3 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.74e-05 | 170 | 22 | 3 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.88e-05 | 171 | 22 | 3 | f9ae7964a3740f559431125c17c660549798cccc | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.15e-05 | 173 | 22 | 3 | ef8d720b99470fe1953661f6e66bc0366266bdb6 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 8.15e-05 | 173 | 22 | 3 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.29e-05 | 174 | 22 | 3 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.29e-05 | 174 | 22 | 3 | 18ab52d8bbca0507fee220e0c4fc765fc47dda34 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.29e-05 | 174 | 22 | 3 | a5f2a4e3b25e6084bd7003a53da86a44f6fcf294 | |
| ToppCell | ASK452-Epithelial-Secretory|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.58e-05 | 176 | 22 | 3 | dd334c8a8a31dc26b2d558df0ef6bed6dc1a6610 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.58e-05 | 176 | 22 | 3 | 77516048aefbe1f48e825052756df0c310c1c486 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.58e-05 | 176 | 22 | 3 | 96779273b94345250cf53ba671203345b43d9e00 | |
| ToppCell | IIH-mDC1-|IIH / Condition, Cell_class and T cell subcluster | 8.58e-05 | 176 | 22 | 3 | bb80a3e595d071f6cc8b042984b8d9490e377eef | |
| ToppCell | IIH-mDC1|IIH / Condition, Cell_class and T cell subcluster | 8.58e-05 | 176 | 22 | 3 | a75dc132a1061006fd1cb305bd314784fca07ea6 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.72e-05 | 177 | 22 | 3 | 16197068260fc062bf8b730a51a199887ea580b9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.87e-05 | 178 | 22 | 3 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 9.17e-05 | 180 | 22 | 3 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.17e-05 | 180 | 22 | 3 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 9.17e-05 | 180 | 22 | 3 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 181 | 22 | 3 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 9.32e-05 | 181 | 22 | 3 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 9.32e-05 | 181 | 22 | 3 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 9.47e-05 | 182 | 22 | 3 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-6_RORB_HPCA|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.63e-05 | 183 | 22 | 3 | c7e94fe3e7669db9304b249979fef7a69c30a143 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.63e-05 | 183 | 22 | 3 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.79e-05 | 184 | 22 | 3 | 9cc5c588f7c6631b3fb8a522214a09ca32947e72 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 9.79e-05 | 184 | 22 | 3 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.79e-05 | 184 | 22 | 3 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 9.79e-05 | 184 | 22 | 3 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 9.94e-05 | 185 | 22 | 3 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 9.94e-05 | 185 | 22 | 3 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.94e-05 | 185 | 22 | 3 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 9.94e-05 | 185 | 22 | 3 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 185 | 22 | 3 | 62cfcb0e2a9e6718e6b200dfbb1a81eaead229b5 | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 9.94e-05 | 185 | 22 | 3 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 9.94e-05 | 185 | 22 | 3 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.94e-05 | 185 | 22 | 3 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.01e-04 | 186 | 22 | 3 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.01e-04 | 186 | 22 | 3 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.01e-04 | 186 | 22 | 3 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.03e-04 | 187 | 22 | 3 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 1.03e-04 | 187 | 22 | 3 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.03e-04 | 187 | 22 | 3 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.04e-04 | 188 | 22 | 3 | 59f276e23c8380bae57d7ecca3a8b83df4bc150b | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.04e-04 | 188 | 22 | 3 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.04e-04 | 188 | 22 | 3 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.04e-04 | 188 | 22 | 3 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 189 | 22 | 3 | 8e6b6025f5554672e26a5d19fe365acb4333789c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 1.06e-04 | 189 | 22 | 3 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.06e-04 | 189 | 22 | 3 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.06e-04 | 189 | 22 | 3 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 1.06e-04 | 189 | 22 | 3 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.06e-04 | 189 | 22 | 3 | 360f09f46231a83f99d8fa0158b72a38068e1642 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-04 | 189 | 22 | 3 | feedac2751ed770f80bc56fec31662b5b3826f58 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.06e-04 | 189 | 22 | 3 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.06e-04 | 189 | 22 | 3 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.08e-04 | 190 | 22 | 3 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 1.08e-04 | 190 | 22 | 3 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 1.08e-04 | 190 | 22 | 3 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.08e-04 | 190 | 22 | 3 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| Disease | Hodgkins lymphoma | 2.65e-05 | 82 | 21 | 3 | EFO_0000183 | |
| Disease | osteosarcoma, overall survival | 3.17e-05 | 12 | 21 | 2 | EFO_0000637, EFO_0000638 | |
| Disease | mood instability measurement | 1.00e-04 | 128 | 21 | 3 | EFO_0008475 | |
| Disease | reading and spelling ability | 2.16e-04 | 166 | 21 | 3 | EFO_0005301 | |
| Disease | trauma exposure measurement | 2.40e-04 | 172 | 21 | 3 | EFO_0010703 | |
| Disease | cardiovascular disease | 2.76e-04 | 457 | 21 | 4 | EFO_0000319 | |
| Disease | Calcium channel blocker use measurement | 4.48e-04 | 213 | 21 | 3 | EFO_0009930 | |
| Disease | heart rate | 5.26e-04 | 225 | 21 | 3 | EFO_0004326 | |
| Disease | sitting height ratio | 6.02e-04 | 51 | 21 | 2 | EFO_0007118 | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 6.02e-04 | 51 | 21 | 2 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | Behcet's syndrome | 6.50e-04 | 53 | 21 | 2 | EFO_0003780 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 8.33e-04 | 60 | 21 | 2 | C4722327 | |
| Disease | Antihypertensive use measurement | 8.45e-04 | 265 | 21 | 3 | EFO_0009927 | |
| Disease | Microcephaly | 1.04e-03 | 67 | 21 | 2 | C0025958 | |
| Disease | Prostate cancer, familial | 1.10e-03 | 69 | 21 | 2 | C2931456 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 1.66e-03 | 335 | 21 | 3 | EFO_0009931 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 1.82e-03 | 346 | 21 | 3 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 2.23e-03 | 801 | 21 | 4 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | Visual seizure | 2.33e-03 | 101 | 21 | 2 | C0270824 | |
| Disease | Epileptic drop attack | 2.33e-03 | 101 | 21 | 2 | C0270846 | |
| Disease | Generalized seizures | 2.33e-03 | 101 | 21 | 2 | C0234533 | |
| Disease | Clonic Seizures | 2.33e-03 | 101 | 21 | 2 | C0234535 | |
| Disease | Vertiginous seizure | 2.33e-03 | 101 | 21 | 2 | C0422855 | |
| Disease | Gustatory seizure | 2.33e-03 | 101 | 21 | 2 | C0422854 | |
| Disease | Seizures, Somatosensory | 2.33e-03 | 101 | 21 | 2 | C0422850 | |
| Disease | Olfactory seizure | 2.33e-03 | 101 | 21 | 2 | C0422853 | |
| Disease | Seizures, Auditory | 2.33e-03 | 101 | 21 | 2 | C0422852 | |
| Disease | Generalized Absence Seizures | 2.33e-03 | 101 | 21 | 2 | C4505436 | |
| Disease | Convulsive Seizures | 2.33e-03 | 101 | 21 | 2 | C0751494 | |
| Disease | Seizures, Sensory | 2.33e-03 | 101 | 21 | 2 | C0751496 | |
| Disease | Atonic Absence Seizures | 2.33e-03 | 101 | 21 | 2 | C0751123 | |
| Disease | Complex partial seizures | 2.33e-03 | 101 | 21 | 2 | C0149958 | |
| Disease | Single Seizure | 2.33e-03 | 101 | 21 | 2 | C0751110 | |
| Disease | Epileptic Seizures | 2.33e-03 | 101 | 21 | 2 | C4317109 | |
| Disease | Jacksonian Seizure | 2.33e-03 | 101 | 21 | 2 | C0022333 | |
| Disease | Non-epileptic convulsion | 2.33e-03 | 101 | 21 | 2 | C0751056 | |
| Disease | Nonepileptic Seizures | 2.33e-03 | 101 | 21 | 2 | C3495874 | |
| Disease | Tonic Seizures | 2.38e-03 | 102 | 21 | 2 | C0270844 | |
| Disease | Absence Seizures | 2.38e-03 | 102 | 21 | 2 | C4316903 | |
| Disease | Convulsions | 2.38e-03 | 102 | 21 | 2 | C4048158 | |
| Disease | Seizures, Focal | 2.47e-03 | 104 | 21 | 2 | C0751495 | |
| Disease | Myoclonic Seizures | 2.47e-03 | 104 | 21 | 2 | C4317123 | |
| Disease | Tonic - clonic seizures | 2.47e-03 | 104 | 21 | 2 | C0494475 | |
| Disease | age at first birth measurement | 3.27e-03 | 120 | 21 | 2 | EFO_0009101 | |
| Disease | depressive symptom measurement | 3.28e-03 | 426 | 21 | 3 | EFO_0007006 | |
| Disease | Tinnitus | 3.83e-03 | 130 | 21 | 2 | HP_0000360 | |
| Disease | corneal resistance factor | 3.84e-03 | 451 | 21 | 3 | EFO_0010067 | |
| Disease | irritable bowel syndrome | 3.89e-03 | 131 | 21 | 2 | EFO_0000555 | |
| Disease | unipolar depression, mood disorder | 4.06e-03 | 134 | 21 | 2 | EFO_0003761, EFO_0004247 | |
| Disease | emphysema imaging measurement | 4.80e-03 | 146 | 21 | 2 | EFO_0007626 | |
| Disease | parental longevity | 4.96e-03 | 494 | 21 | 3 | EFO_0007796 | |
| Disease | diabetic nephropathy | 5.06e-03 | 150 | 21 | 2 | EFO_0000401 | |
| Disease | mean arterial pressure | 5.10e-03 | 499 | 21 | 3 | EFO_0006340 | |
| Disease | intraocular pressure measurement | 5.39e-03 | 509 | 21 | 3 | EFO_0004695 | |
| Disease | major depressive disorder | 5.39e-03 | 155 | 21 | 2 | MONDO_0002009 | |
| Disease | unipolar depression, bipolar disorder | 5.46e-03 | 156 | 21 | 2 | EFO_0003761, MONDO_0004985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HEVNIMWAGHQTHHS | 136 | Q6ZNB7 | |
| SSWHVMSVIFHSDKH | 116 | Q5VXM1 | |
| HMHSDHTVGLSSTWA | 31 | Q9H816 | |
| HSTSHSSSNVWHSMA | 1201 | Q03112 | |
| HHSSDPWSSSSGMNQ | 221 | P15884 | |
| SSSHWHQEGVDVKTM | 506 | Q9NZ08 | |
| SSEMHSLHNHLQSPW | 676 | Q5W0B1 | |
| SMKSSHQKPSGCWQH | 71 | Q969J5 | |
| QDSVKWHHMAHKVNS | 16 | Q5TGP6 | |
| SQWMHSTSSHEGHKQ | 1421 | Q96BY6 | |
| HMQHSKWQHPSDLTT | 356 | Q96BU1 | |
| MQDSAIDSSSKDHHW | 1206 | Q12923 | |
| TVSNLWNSTHHVFMH | 546 | Q15262 | |
| MVAAHAAHSSSSAEW | 1 | Q8WZA2 | |
| SSTKHWASMHVSDHS | 221 | Q7Z6K3 | |
| QTSMDHSHHWVFLGN | 926 | Q6IEE7 | |
| TGDSAHNQAMVHWSG | 191 | Q9UPU3 | |
| HNQAMVHWSGHNSSV | 196 | Q9UPU3 | |
| STISAHSNPVHWQHM | 241 | O75970 | |
| WSSSLANHKSMHTGE | 391 | Q8IYX0 | |
| TWSSTLHNHVRMHTG | 486 | Q68EA5 | |
| SAHNQAMVHWSGHNS | 171 | Q8WY21 | |
| GGHINSHDVWMFSSH | 356 | Q6PF15 |